Global Newcastle Disease Vaccine Market Size By Vaccine Type (Live Attenuated, Inactivated & Thermostable), By Species (Chicken, Duck & Goose), By Geographic Scope And Forecast

Newcastle Disease Vaccine Market Size And Forecast

Newcastle Disease Vaccine Market size was valued at USD 289.27 Million in 2024 and is projected to reach USD 372.16 Million by 2031, growing at a CAGR of 3.20% from 2024 to 2031.

• Newcastle disease is a severe viral sickness in birds caused by avian paramyxovirus type 1 (APMV-1). It is very contagious and can spread too many domestic birds, including chickens and turkeys, with hens being especially vulnerable. The virus is spread by the fecal-oral route, which means that birds become infected after consuming contaminated droppings, food, drink, or equipment that has come into contact with sick birds.
• According to Commercial market turkeys spray-vaccinated at 2 to 3 weeks of age with live Newcastle disease virus (NDV) vaccine did not often generate high or persistent serum antibody levels as detected by the hemagglutination-inhibition test. Vaccinated turkeys demonstrated adequate resistance to infection and clinical disease when challenged by the oculonasal or aerosol route at 2 weeks post-vaccination, and they resisted clinical disease when challenged at 6 weeks, but the level of protection decreased by 10 weeks post-vaccination.
• It is proposed that market turkeys raised in an NDV-enzootic environment may require two or more NDV spray vaccinations during their developing phase in order to be fully protected against natural NDV infection.
• The increasing incidence of severe respiratory distress and nervous difficulties in birds contributes to the huge expansion of the Newcastle Disease Vaccine Market. Expanding outbreaks of the disease, expanding demand for livestock for food, and continuous research to produce a treatment for this disease are expected to drive market expansion. The Newcastle Disease Vaccine Market is thriving as people become more aware of the benefits of maintaining good health, resulting in a greater demand for high-quality healthcare services among consumers.

Newcastle Disease Vaccine Market Dynamics

The key market dynamics that are shaping the global Newcastle disease vaccine market include

Key Market Drivers

• Disease Prevalence The presence of Newcastle disease (ND) in poultry populations is a major driver of the Newcastle disease vaccine industry. As ND continues to affect poultry farms around the world, there is a great demand for effective vaccines to prevent the disease from spreading.
• Growth of the Poultry Industry The expansion of the poultry industry, fueled by rising global demand for chicken products such as meat and eggs, helps to drive the Newcastle disease vaccine market. As chicken production increases and spreads into new areas, the necessity for comprehensive immunization programs becomes increasingly pressing.
• Environmental and Biosecurity Concerns Growing concern about biosecurity and the environmental impact of disease outbreaks is driving the use of preventive measures like immunization. Proactive steps to avoid Newcastle disease can save the environment while also ensuring the long-term viability of chicken production systems.
• Disease Outbreaks Newcastle disease outbreaks, particularly in poultry-producing regions, lead to intensified immunization efforts and generate market demand for Newcastle disease vaccines. Outbreaks can cause large economic losses for poultry producers, highlighting the significance of effective vaccination efforts.

Key Challenges

• Cost Constraints The high cost of Newcastle disease vaccines can deter adoption, especially among small-scale chicken breeders with limited financial resources. Developing economical vaccine formulations and adopting cost-effective immunization procedures is critical for ensuring widespread acceptance and disease control particularly in low-income nations.
• Increased Biosecurity Awareness As Newcastle disease outbreaks become more common and extensive, farmers recognize the significance of biosecurity measures to protect their flocks. Vaccination is a critical component of biosecurity measures, which is boosting the demand for Newcastle disease vaccine.
• Emergence of New StrainsThe Newcastle disease virus is constantly mutating, with new and more aggressive strains appearing. These novel strains may render current vaccines ineffective, prompting the creation of new and improved vaccines. This can be a long and costly process.
• Limited Access to Vaccines Some impoverished countries have limited access to veterinary vaccines, such as Newcastle disease vaccines. This is due to a variety of issues, including inadequate infrastructure, money, and awareness. Farmers in these nations have fewer options for protecting their animals from Newcastle disease.

Key Trends

• Rising Demand for Chicken Products The global population’s expanding appetite for poultry meat and eggs has resulted in increased poultry production. This increases the need for immunization to protect birds from Newcastle disease outbreaks, which may kill chicks and result in considerable economic losses.
• Increasing Knowledge of Newcastle Disease’s Economic Impact Poultry growers are becoming more conscious of the financial losses caused by Newcastle disease. This includes avian mortality, reduced egg output, and trade restrictions. Vaccination is viewed as a cost-effective method of preventing these losses.
• Advances in Vaccination Technology Research and development are underway to build more effective and thermostable Newcastle disease vaccines. This is especially significant in areas with limited refrigeration access, as it facilitates vaccine storage and distribution.
• Government Laws and Immunization Programs Many governments have adopted mandatory vaccination programs against Newcastle disease in chicken. This helps to control disease spread while also protecting the poultry business.

Global Newcastle Disease Vaccine Market Regional Analysis

Here is a more detailed regional analysis of the global Newcastle disease vaccine market

North America

• The Newcastle disease vaccine market, owing to a robust chicken sector and high demand for poultry products, including meat and eggs. The region’s chicken industry is well-established, but Newcastle disease poses ongoing challenges needing stringent preventive measures such as immunization. This need emphasizes the importance of Newcastle disease vaccines in protecting the region’s poultry stock and assuring the continuation of its thriving poultry market.
• Furthermore, North America’s unwavering dedication to sustainable agriculture techniques and animal welfare encourages the use of Newcastle disease vaccines. Prioritizing poultry health and well-being demonstrates the region’s commitment to sustaining high food safety and animal care standards, which resonates positively with both consumers and industry stakeholders.
• North America’s dominant market position not only represents its enormous contribution to the global Newcastle disease vaccine market, but also demonstrates its unwavering commitment to safeguarding the poultry industry’s viability and resilience in the face of evolving disease threats.

Asia Pacific

• The Asia-Pacific region is expected to lead the Newcastle disease vaccine market, as it is home to some of the world’s top poultry producers, including China, India, and Indonesia. Here, rising demand for poultry products, fueled by population growth and changing dietary habits, drives the need to protect poultry flocks from Newcastle disease outbreaks. As a result, there is a significant increase in demand for vaccines, emphasizing the importance of preventive measures in supporting the region’s thriving poultry sector.
• Furthermore, the Asia-Pacific area is experiencing tremendous development in the poultry business, as well as increased knowledge of biosecurity regulations. This double momentum not only strengthens the Newcastle disease vaccine market but also demonstrates the region’s proactive approach to disease prevention in chicken production. These factors firmly position Asia-Pacific as a key catalyst for Newcastle disease vaccine market growth, demonstrating its critical role in maintaining the global poultry industry’s resilience in the face of changing challenges.

Europe

• The European market is primed to emerge as a serious competitor, boosted by proactive government programs that assist research and development efforts, particularly in the field of Newcastle disease vaccines. With significant investments in improving veterinary science and tight regulatory frameworks, the region creates an atmosphere conducive to innovation in animal health solutions.
• Furthermore, Europe’s significant advancements in animal husbandry procedures strengthen its position in the Newcastle disease vaccine market. By embracing innovative techniques and technology aimed at improving animal welfare and disease prevention, the region demonstrates its commitment to upholding high animal health and food safety standards. This combination of government funding, scientific excellence, and modern husbandry techniques puts Europe as a major player set to make great advances in the international Newcastle disease vaccine market.

Global Newcastle Disease Vaccine MarketSegmentation Analysis

The Global Newcastle Disease Vaccine Market is segmented on the basis of Vaccine Type, Species, And Geography.

Newcastle Disease Vaccine Market, By Vaccine Type

• Live Attenuated
• Inactivated
• Thermostable

Based on Vaccine Type, the market is divided into Live Attenuated, Inactivated and Thermostable. The Live Attenuated Vaccines (LAV) segment dominated the market in 2022 and is expected to have the highest compound annual growth rate (CAGR) over the forecast period. LAVs have remained popular among poultry breeders due to their effectiveness, low cost, and potential to provide long-term immunity. These vaccines have demonstrated efficacy against many strains of Newcastle disease viruses and provide broad-spectrum protection.

Newcastle Disease Vaccine Market, By Species

• Chicken
• Duck
• Goose

Based on Species, the Newcastle disease vaccine market is segmented Chicken, Duck and Goose. The chicken sector grabbed the biggest market share and is expected to retain a significant compound annual growth rate (CAGR) over the projection period. Newcastle Disease Virus (NDV) is a major threat to the poultry industry, causing significant economic losses. As a result, the demand for Newcastle Disease Vaccines remains high among chicken farmers, making this segment the most profitable in the market.

Newcastle Disease Vaccine Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

On the basis of regional analysis, the Global Newcastle Disease Vaccine Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the largest market share of Newcastle disease vaccine followed by Europe. Growing demand for effective emergency care and increasing adoption of mobile surgery centers are anticipated to drive the industry during the forecast period.

Key Players

The “Global Newcastle disease vaccine Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Merial, QYH Biotech, CEVA, Yebio, Ringpu (Tianjin) Bio-Pharmacy Co. Ltd,Bayer AG, Hipra,  Anicon Labor GmbH, Chengdu Tech-bank Biological Products Co. Ltd., Ringpu Bio-Technology Co. Ltd., MSD Animal Health, Nisseiken Co., Harbin Veterinary Research Institute, Merck Animal Health, ChengDu Tecbond, DHN, Zoetis, Elanco (Lohmann), CAVAC, Vaksindo, FATRO. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Newcastle Disease Vaccine Market Recent Developments

• In June 2022, Ceva Santé bought Canadian firm Artemis Technologies, Inc. to extend its oral rabies vaccine line. Ceva’s North American presence will be expanded as a result of this transaction.
• In April 2020, The Indian Institute of Technology Guwahati and Hester Biosciences cooperated to create a new coronavirus vaccine (COVID-19). The vaccine is based on a recombinant avian paramyxovirus vector platform.

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.